(Q45091813)

9 December 2017

title

A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer (English)

1 reference

9 December 2017

1 reference

J Norum

1

1 reference

9 December 2017

J A Olsen

series ordinal

2

1 reference

9 December 2017

language of work or name

1 reference

1 November 1997

1 reference

9 December 2017

1 reference

9 December 2017

volume

8

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

1081-1087

1 reference

CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Disease-free survival and recurrence after resection of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Value of outpatient follow-up after curative surgery for carcinoma of the large bowel.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Does the breast cancer dollar make sense?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Follow-up of patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Colorectal cancer. Principles of postoperative follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Treatment costs in Hodgkin's disease: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Reoperation directed by carcinoembryonic antigen level: the importance of a thorough preoperative evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008265614183

7 January 2021

Identifiers

DOI

10.1023/A:1008265614183

1 reference

release_z5vfuct76rde5fbvauuz2pttdq

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z5vfuct76rde5fbvauuz2pttdq

24 November 2022

mapped directly with Wikidata item

1 reference